Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
9.79
-0.06 (-0.61%)
Apr 19, 2024, 2:23 PM EDT - Market open
Annovis Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Annovis Bio stock have an average target of 25, with a low estimate of 9.00 and a high estimate of 36. The average target predicts an increase of 155.36% from the current stock price of 9.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Annovis Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +206.44% | Apr 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +206.44% | Mar 21, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades $9 | Strong Buy → Hold | Downgrades | $9 | -8.07% | Feb 28, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +267.72% | Dec 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +206.44% | Nov 28, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.11
from -6.23
EPS Next Year
-2.57
from -2.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 34.5M |
| Avg | n/a | n/a | 16.7M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.07 | -2.33 | -2.90 |
| Avg | -2.11 | -2.57 | -2.82 |
| Low | -2.12 | -2.76 | -2.70 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.